REQUEST A DEMO
Total
USD $0.00
Search more companies

Worwag Pharma Cesko S.R.O. (Czech Republic)

Main Activities: Advertising Agencies
Secondary Activities: Office Administrative Services
Full name: Worwag Pharma Cesko S.R.O. Profile Updated: December 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Worwag Pharma Cesko S.R.O. is a company based in Czech Republic, with its head office in Prague. The company operates in the Advertising Agencies industry. It was first established on August 01, 2020. There are currently 20 - 24 (2023) people employed by Worwag Pharma Cesko S.R.O.. From the latest financial highlights, Worwag Pharma Cesko S.R.O. reported a net sales revenue increase of 19.85% in 2024. Its total assets grew by 103.93% over the same period. In 2024, Worwag Pharma Cesko S.R.O.’s net profit margin increased by 0.87%.

Headquarters
Bucharova 2657/12
Prague; The City of Prague; Postal Code: 15800

Contact Details: Purchase the Worwag Pharma Cesko S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Worwag Pharma Cesko S.R.O. report to view the information.
Registered Capital:
Purchase the Worwag Pharma Cesko S.R.O. report to view the information.
Financial Auditors:
Purchase the Worwag Pharma Cesko S.R.O. report to view the information.
Incorporation Date:
August 01, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Worwag Pharma Cesko S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
19.85%
Total operating revenue
19.64%
Operating profit (EBIT)
47.12%
EBITDA
32.14%
Net Profit (Loss) for the Period
50.13%
Total Assets
103.93%
Total Equity
27.64%
Operating Profit Margin (ROS)
1.15%
Net Profit Margin
0.87%
Return on Equity (ROE)
8.78%
Quick Ratio
0.01%
Cash Ratio
0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?